Therapeutic Keratoplasty for Severe, Travel-Associated Fungal Keratitis: A Meta-Analysis of Globe Salvage and Visual Acuity Outcomes

Authors

  • Putu Rima Adilitha Widyasari Department of Ophthalmology, Faculty of Medicine, Universitas Udayana/Prof. Dr. I.G.N.G. Ngoerah General Hospital, Denpasar, Indonesia
  • I Made Ady Wirawan Faculty of Medicine, Universitas Udayana, Denpasar, Indonesia
  • I Gusti Ayu Made Juliari Department of Ophthalmology, Faculty of Medicine, Universitas Udayana/Prof. Dr. I.G.N.G. Ngoerah General Hospital, Denpasar, Indonesia
  • Ida Ayu Ary Pramita Department of Ophthalmology, Faculty of Medicine, Universitas Udayana/Prof. Dr. I.G.N.G. Ngoerah General Hospital, Denpasar, Indonesia

DOI:

https://doi.org/10.37275/bsm.v9i12.1457

Keywords:

Fungal keratitis, Globe salvage, Keratomycosis, Therapeutic keratoplasty, Travel medicine

Abstract

Background: Severe, travel-associated fungal keratitis represents a formidable diagnostic and therapeutic challenge, often progressing to corneal perforation despite aggressive medical therapy. Therapeutic keratoplasty (TK) is frequently required to preserve globe integrity. However, its efficacy in this specific, epidemiologically distinct cohort of patients remains poorly quantified. This meta-analysis aimed to synthesize the available evidence on globe salvage and visual acuity outcomes following TK for severe fungal keratitis acquired during international travel.

Methods: A systematic search was conducted in PubMed, Scopus, and Web of Science for studies published between January 2015 and December 2024, reporting outcomes of TK for travel-associated fungal keratitis. The primary outcome was the proportion of cases achieving globe salvage, defined as the avoidance of enucleation or evisceration. The secondary outcome was the mean improvement in Best-Corrected Visual Acuity (BCVA) measured in LogMAR units. Data were pooled using a random-effects model. Heterogeneity was assessed using the I² statistic.

Results: Seven retrospective case series met the inclusion criteria, comprising a total of 102 eyes. The included studies were geographically diverse, with patient travel histories predominantly linked to tropical and subtropical regions in Southeast Asia and South America. The pooled proportion for globe salvage was 89.2% (95% Confidence Interval [CI]: 82.5% to 94.1%). There was low to moderate heterogeneity among the studies for this outcome (I² = 31%, p=0.19). The pooled mean improvement in BCVA from pre-operative assessment to final follow-up was 1.21 LogMAR (95% CI: 0.98 to 1.44). Substantial heterogeneity was observed for the visual acuity outcome (I² = 78%, p<0.001). The most commonly identified fungal genera were Fusarium and Aspergillus.

Conclusion: Therapeutic keratoplasty demonstrates a high rate of anatomical success, effectively salvaging the globe in the vast majority of patients with severe, travel-associated fungal keratitis. While visual acuity is significantly improved, the final outcomes remain guarded and are highly variable. These findings underscore the critical role of TK in the management of this sight-threatening condition and highlight the need for strategies to improve post-operative visual prognosis.

Authors

  • Putu Rima Adilitha Widyasari1*
  • I Made Ady Wirawan2
  • I Gusti Ayu Made Juliari1
  • Ida Ayu Ary Pramita1
  1. 1Department of Ophthalmology, Faculty of Medicine, Universitas Udayana/Prof. Dr. I.G.N.G. Ngoerah General Hospital, Denpasar, Indonesia
  2. 2Faculty of Medicine, Universitas Udayana, Denpasar, Indonesia

Corresponding author Putu Rima Adilitha Widyasari — rimaadilitha18@gmail.com

Article history

  1. Submitted
  2. Accepted
  3. Published

Downloads

Published

2025-09-26

Article metrics

386Abstract views
268PDF downloads

How to Cite

1.
Putu Rima Adilitha Widyasari, I Made Ady Wirawan, I Gusti Ayu Made Juliari, Ida Ayu Ary Pramita. Therapeutic Keratoplasty for Severe, Travel-Associated Fungal Keratitis: A Meta-Analysis of Globe Salvage and Visual Acuity Outcomes. Bioscmed [Internet]. 2025 Sep. 26 [cited 2026 Aug. 12];9(12):9775-89. Available from: https://bioscmed.com/index.php/bsm/article/view/1457

Most read articles by the same author(s)

1 2 > >>